Erwin Troxler
Director of Finance/CFO chez HBM HEALTHCARE INVESTMENTS AG
Fortune : 1 M $ au 31/03/2024
Provenance du réseau au premier degré de Erwin Troxler
Entité | Type d'entité | Industrie | |
---|---|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.
26
| Private Company | Investment Managers | 26 |
Venture Capital Fund | Investment Managers | 10 | |
Schweizer Verband der Investmentgesellschaften
3
| Private Company | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Erwin Troxler via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ROCHE HOLDING AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tensys Medical, Inc.
Tensys Medical, Inc. Medical/Nursing ServicesHealth Services Tensys Medical, Inc. develops blood pressure monitoring systems. The firm provides patient safety by designing, and manufacturing continuous, non-invasive hemodynamic monitoring systems. The company was founded in 1995 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member Chairman | |
Gynesonics, Inc.
Gynesonics, Inc. Medical SpecialtiesHealth Technology Gynesonics, Inc. provides medical devices for women's health. It offers VizAblate System for the transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The company was founded by Jessica grossman in 2005 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member | |
TIGENIX NV | Medical Specialties | Director/Board Member | |
Alpha Associates AG
Alpha Associates AG Investment ManagersFinance Alpha Associates AG is an independent private equity firm headquartered in Zurich, Switzerland. Established in 2004, the firm provides private equity solutions and advice for institutional clients, family offices and high-net worth individuals. The firm also manages private equity fund-of-funds programs. | Investment Managers | Private Equity Analyst | |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
INSEAD | College/University | Masters Business Admin | |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
University of St. Gallen | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
CardiacAssist, Inc.
CardiacAssist, Inc. Medical SpecialtiesHealth Technology CardiacAssist, Inc. develops, manufactures and markets medical devices. The firm’s products include TandemLife Kit, TandemHeart Kit, TandemLung Kit, ProtekDuo Kit and educational videos. The company was founded by John C. Marous, Jr. and George J. Magovern in 1996 and is headquartered in Pittsburgh, PA. | Medical Specialties | Director/Board Member | |
Horizon21 AG
Horizon21 AG Financial ConglomeratesFinance Part of SO Holding AG, Horizon21 AG is a Swiss company that provides private equity services. The company is based in Pfäffikon, Switzerland. The company was founded by Rainer-Marc Frey, Adrian Gut. | Financial Conglomerates | Corporate Officer/Principal | |
University of Basel | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
University of Zurich | College/University | Doctorate Degree Doctorate Degree | |
Freie Universität Berlin | College/University | Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
University of Bern | College/University | Doctorate Degree Doctorate Degree | |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
i-Optics BV
i-Optics BV Medical SpecialtiesHealth Technology i-Optics BV develops and produces eye diagnosis and therapeutic solutions. Its lead product, the EasyScan, that provides non-mydriatic retina imaging camera for the diagnosis of diabetic retinopathy and macular degeneration. The firm engages in the development and marketing of retina and cornea imaging solutions. The company was founded by Michiel Mensink and is headquartered in The Hague, the Netherlands. | Medical Specialties | Director/Board Member | |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Investment Managers | Chairman | |
NOVIMMUNE SA | Medical/Nursing Services | Chairman | |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
MLL Meyerlustenberger Lachenal Froriep AG
MLL Meyerlustenberger Lachenal Froriep AG Miscellaneous Commercial ServicesCommercial Services MLL Meyerlustenberger Lachenal Froriep AG is a leading law firm in Switzerland that provides legal advice to companies from all over the world. The private company was founded in 1882 and is based in Zurich, Switzerland, with subsidiaries in Switzerland, including offices in Geneva, Zug, and others. The firm utilizes Legal Tech as collaboration and communication tools, as well as in their service offerings. MLL Legal has expertise in various areas such as industry groups, country desks, and special desks. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Rozag Gruppe | Director/Board Member | ||
HBM Healthcare Investments (Cayman) Ltd.
HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The private company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. | Hospital/Nursing Management | Chief Executive Officer Director/Board Member Director/Board Member | |
HBM Partners AG (Investment Management)
HBM Partners AG (Investment Management) Investment ManagersFinance HBM Partners AG (Investment Management) (HBM-IM) is the asset management division of HBM Partners AG. The firm is headquartered in Zug and was founded in 2001. HBM-IM provides investment advisory services to private companies. They manage the fund HBM Healthcare Investments. | Investment Managers | Chief Executive Officer Portfolio Manager-Equities Analyst-Equity Portfolio Manager-Equities | |
Swiss Cancer Foundation | Director/Board Member | ||
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
Kellogg School of Management | College/University | Graduate Degree | |
Müller-Steinag Element AG
Müller-Steinag Element AG Construction MaterialsNon-Energy Minerals Müller-Steinag Element AG is a private company based in Rickenbach, Switzerland. The Swiss company specializes in providing a diverse range of aesthetic and beautiful outdoor furniture, embankments, garden equipment, walls, natural building materials, and paths. The company is committed to building the world with the best quality concrete and customized developments for every requirement. The company's product range includes outdoor furniture, embankments, garden equipment, walls, natural building materials, and paths. | Construction Materials | Director/Board Member | |
NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Swixx Biopharma SA
Swixx Biopharma SA Miscellaneous Commercial ServicesCommercial Services Swixx Biopharma SA provides marketing and sales, regulatory, medical affairs, cold chain, logistic services to pharmaceutical companies. Its services also include receivables, collection, FX coverage, risk management, compliance, and reimbursement and market access. The company was founded by Petr Nemec and Robert Stuart Swanson in 2013 and is headquartered in Baar, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Crypto Finance AG
Crypto Finance AG Financial ConglomeratesFinance Crypto Finance AG operates as a financial technology holding company. It provides blockchain-related services through its subsidiaries: Crypto Fund AG (Asset Management), Crypto Broker AG (Brokerage), and Crypto Storage AG (Storage). The company was founded by Jan Brzezek and Tobias Reichmuth in June 2017 and is headquartered in Zug, Switzerland. | Financial Conglomerates | Director/Board Member | |
Dren Bio, Inc.
Dren Bio, Inc. BiotechnologyHealth Technology Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
River 2 Renal Corp.
River 2 Renal Corp. Pharmaceuticals: MajorHealth Technology River 2 Renal Corp. develops novel therapies targeting orphan diseases in the renal space. The private company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
River 3 Renal Corp. | Director/Board Member | ||
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Founder Director/Board Member |
Statistiques
Internationale
Suisse | 24 |
Etats-Unis | 16 |
Allemagne | 5 |
Irlande | 2 |
Belgique | 2 |
Sectorielle
Health Technology | 24 |
Consumer Services | 9 |
Finance | 8 |
Commercial Services | 6 |
Health Services | 4 |
Opérationnelle
Director/Board Member | 246 |
Chairman | 64 |
Corporate Officer/Principal | 62 |
Independent Dir/Board Member | 51 |
Private Equity Investor | 26 |
Relations les plus connectées
Insiders | |
---|---|
Robert Alexander Ingram | 43 |
Elaine Jones | 37 |
Erich Maximilian Platzer | 31 |
Gerald Heinz Möller | 29 |
Hans-Peter Hasler | 28 |
Axel Bolte | 23 |
Chandra Paul Leo | 22 |
André L. Lamotte | 21 |
Andreas Wicki | 21 |
Mario Giuliani | 19 |
Alexander G. Asam | 18 |
Thomas Thaler | 17 |
Alexander Vogel | 16 |
Stella Xu | 14 |
Michael Jasulavic | 12 |
- Bourse
- Insiders
- Erwin Troxler
- Connexions Sociétés